Jacques Noble

Diabetes and Cardiovascular Disease

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Chagas disease

Survivors of out-of-hospital cardiac arrest with apparently normal heart: Need for definition and standardized clinical evaluation

Anaesthesia, surgery, and challenges in postoperative recovery

Cholesterol Risk Management: A Systematic Examination of the Gap from Evidence to Practice

Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia

Screening and treating adults for lipid disorders21Reprints are available from the AHRQ Web site at www.ahrq.gov/clinic/uspstfix.htm, through the National Guideline Clearinghouse (www.guideline/gov), or in print through the AHRQ Publications Clearinghouse (1-800-358-9295).22The USPSTF recommendations based on this evidence review can be found in Screening Adults for Lipid Disorders: Recommendations and Rationale, available elsewhere in this supplement and from the AHRQ Web site and clearinghouse.

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Myocardial bridging in adult patients with hypertrophic cardiomyopathy

Childhood obesity: public-health crisis, common sense cure

Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies

The value of changes in QRS width and in ST-T segment during exercise test in hypertrophic cardiomyopathy for identification of associated coronary artery disease

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

Exercise Standards for Testing and Training

Relation among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease

Percutaneous bypass: subintimal recanalization of peripheral occlusive disease with IVUS guided luminal re-entry

Natural history of hypertrophic cardiomyopathy

Myocardial Bridging in Children with Hypertrophic Cardiomyopathy — A Risk Factor for Sudden Death

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction

Preventive Medicine and Screening in Older Adults

Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes

Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes

Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy

Congenital Heart Surgery Nomenclature and Database Project: anomalies of the coronary arteries

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

Combination Spinal Analgesic Chemotherapy: A Systematic Review

Results of percutaneous transluminal coronary angioplasty by multiple, relatively low frequency operators: 1986–1987 experience

Stenting in chronic coronary occlusion (SICCO): A randomized, controlled trial of adding stent implantation after successful angioplasty

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy

The challenge of cardiomyopathy

Myocardial Substrate Metabolism in the Normal and Failing Heart

Myocarditis

Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease

Functional, angiographic and intracoronary doppler flow characteristics in symptomatic patients with myocardial bridging: Effect of short-term intravenous beta-blocker medication

Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women

Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study

Histologic Correlates of Angiographic Chronic Total Coronary Artery Occlusions

Hypertrophic Cardiomyopathy

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits

The Prevalence and Anatomical Patterns of Intramuscular Coronary Arteries

Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost

The Management of Hypertrophic Cardiomyopathy

Non-atherosclerotic coronary artery disease and sudden death in the young

The effects of a myocardial bridge on coronary atherosclerosis and ischaemia

Re-Stenosis after Successful Coronary Angioplasty

Prequtaneous transluminal angioplasty in patients with multivessel coronary disease: How important is complete revascularization for cardiac event-free survival?

The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy

Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death

Heart disease and other causes of sudden death in young athletes

Normal and anomalous coronary arteries: Definitions and classification

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

Hypertrophic Cardiomyopathy and Sudden Death

Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults

Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe

Massively parallel kinetic profiling of natural and engineered CRISPR nucleases

Current methods of the U.S. Preventive Services Task Force

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial

The Progression From Hypertension to Congestive Heart Failure

Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions

Interventions for providers to promote a patient-centred approach in clinical consultations

Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction

Decreased Coronary Flow Reserve in Hypertrophic Cardiomyopathy Is Related to Remodeling of the Coronary Microcirculation

Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy

Myocardial bridges: A review

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits

Targeting G _βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis

Persistence of Use of Lipid-Lowering Medications

Diabetic Cardiomyopathy

Guidelines for the Primary Prevention of Stroke

Mechanisms of Plaque Formation and Rupture

Association of Coronary Heart Disease Risk Factors With Microscopic Qualities of Coronary Atherosclerosis in Youth

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Primary Prevention of Coronary Heart Disease: Guidance From Framingham

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

ACSM Position Stand: Exercise and Physical Activity for Older Adults

QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse

Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.

Sudden Cardiac Death

A Systematic Review of Adherence With Medications for Diabetes

Pathogenesis of Chronic Chagas Heart Disease

Regulation of Trypanosoma cruzi-Induced Myocarditis by Programmed Death Cell Receptor 1

Smooth Muscle Cell Proliferation Is Proportional to the Degree of Balloon Injury in a Rat Model of Angioplasty

Current perspectives in coronary microvascular dysfunction

Myocardial bridging and hypertrophic cardiomyopathy: relief of ischemia by surgery

Thermal Preconditioning Before Rat Arterial Balloon Injury

Effects of Serum Lipoproteins and Smoking on Atherosclerosis in Young Men and Women

ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies

Chest pain and “normal” coronary arteries—Role of small coronary arteries

Hypertrophic Cardiomyopathy With Apical Left Ventricular Aneurysm

Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy

Combination Spinal Analgesic Chemotherapy: A Systematic Review

Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy

Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

Coronary Artery Anomalies

Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure

Hypertrophic Cardiomyopathy

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy

Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy

Effect of Physician-Delivered Nutrition Counseling Training and an Office-Support Program on Saturated Fat Intake, Weight, and Serum Lipid Measurements in a Hyperlipidemic Population

Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults

Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.

The effects of intrathecal midazolam on sympathetic nervous system reflexes in man‐a pilot study.

The systolic click syndrome: An “ischemic” cardiomyopathy?

Percutaneous transluminal coronary angioplasty by high‐volume and low‐volume operators

Successful Course After Supraarterial Myotomy for Myocardial Bridging and Milking Effect of the Left Anterior Descending Artery

Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion

Myocardial bridging and milking effect of the left anterior descending coronary artery: Normal variant or obstruction?